Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications european “real world” evidence drugs devices 2017 literature reviewed
… place you turn when you need substantiated, authoritative evidence and advice. We are scientists first—academically … to apply the appropriate research methodologies to your real-world applications and situations. We care about doing what’s …
… from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and … Dossier: to communicate information (clinical and economic evidence) about an approved product; provided based on an …
… of the health technology assessment (HTA) process on a European-wide level. The 4 clinical domains are: current use … HTA Regulation (HTAR), which applies to all new oncology drugs and cell and gene therapies beginning January 2025, … It also means that the clinical efficacy and safety evidence submitted as part of the EMA regulatory dossier will …
… the Medicare system is becoming a reality. The first 10 drugs have been selected for the new Medicare Drug Price … In 2024, 15 more drugs will be chosen for the program. European Health Technology Assessment Regulation The European Regulation on Health Technology Assessment (HTAR) is …
… and consultancy experience in market access strategies and evidence generation. Below, she shares how she is seeing … Because small molecules or multiple-indication orphan drugs are disincentivised by the Inflation Reduction Act … Costs Emergence of the Joint Clinical Assessment in the European Union and the Inflation Reduction Act in the United …
… 2022 Conference Website Advancing Pharmacoepidemiology and Real-World Evidence for the Global Community We were excited for the …
… heart attacks, anginas, and arrhythmias. In 2013, the European Medicines Agency evaluated the benefits and risks of … of cilostazol in Europe. The study was conducted in 5 European populations - Aragon and Catalonia in Spain, Sweden, … all study populations, and use of 2 or more antiplatelet drugs decreased in the United Kingdom, Spain, and Sweden. …
… brave, ask questions. They taught me to apply concepts to real-world problems.” “I'm fortunate to work with RTI Health …
… a global value dossier (GVD) that effectively presents evidence-based messages and scientific … research findings and value must be clearly articulated, evidence-driven, and tailored to target audiences. Proven … submission adaptation and platforms for communicating GVD evidence. You’ll learn how to: Develop information that will …
… A recent study by two RTI-HS researchers published in CNS Drugs found which of those two treatments is more …